ACIU AC Immune SA
$2.25▼ -2.60%
Healthcare
Other
Volume 469.0K
Avg Volume (10D) 154.7K
Key Metrics & Fundamentals
Market Cap
$223.71M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.03 - 4.00
% vs 50 MA
-14.45%
% vs 200 MA
-18.06%
RSI-14
34.5
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.40
Gross Rev
$15.11M
Gross Profit
$15.11M
EBITDA
$1.36M
COGS
–
Operating Exp
$13.92M
Operating Income
$1.19M
EBIT
$1.19M
Pretax Income
$1.87M
Net Income
$1.87M
Price & Volume History
Loading chart…
Recent News
INSM Stock Slides on CFO Exit, Reiterates '26 Sales View
Zacks · Oct 6, 2026 10:29 AM ET
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know
Zacks · Oct 6, 2026 9:55 AM ET
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal
Zacks · Oct 6, 2026 9:30 AM ET
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
Zacks · Oct 5, 2026 11:21 AM ET
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
Zacks · Oct 5, 2026 10:46 AM ET
Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work
Zacks · Oct 5, 2026 10:36 AM ET
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
Zacks · Oct 1, 2026 11:16 AM ET
Novo's Wegovy Pill Shows Weight Loss After Switching From Injections
Zacks · Oct 1, 2026 9:42 AM ET
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
Zacks · Oct 1, 2026 8:55 AM ET
NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk
Zacks · Sep 30, 2026 1:34 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ACIU's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.